These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7979086)

  • 1. Somatostatin and the treatment of pancreatic cancer.
    Hughes O; Sharma V; Appanna T; Lewis MH
    Ann R Coll Surg Engl; 1994 Sep; 76(5):354. PubMed ID: 7979086
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of pancreatic apudomas with a somatostatin analog SMS 201-995].
    Varas Lorenzo MJ
    Med Clin (Barc); 1988 Dec; 91(20):796. PubMed ID: 3236932
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological treatment of gastroenteropancreatic apudomas with an analog of somatostatin, SMS 201-995 (octreotide)].
    Varas Lorenzo MJ
    Rev Esp Enferm Dig; 1991 Feb; 79(2):95-8. PubMed ID: 2059523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.
    Butturini G; Bettini R; Missiaglia E; Mantovani W; Dalai I; Capelli P; Ferdeghini M; Pederzoli P; Scarpa A; Falconi M
    Endocr Relat Cancer; 2006 Dec; 13(4):1213-21. PubMed ID: 17158766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
    Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
    Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
    Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin analogue therapy in functioning neuroendocrine gut tumors.
    Debas HT; Gittes G
    Digestion; 1993; 54 Suppl 1():68-71. PubMed ID: 8359571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity of cancers of the endocrine pancreas to chemotherapy].
    Chamseddine N; Auclerc MF; Khayat D; Jacquillat C; Hecht Y; Ferrier JP
    Nouv Presse Med; 1982 Jun; 11(28):2153. PubMed ID: 7050903
    [No Abstract]   [Full Text] [Related]  

  • 9. [Octreotide in the treatment of advanced pancreatic tumor. Preliminary study].
    Cirillo F; Bottini A; Brunelli A; Zuffada S; Bassi M; Filippini L; Alquati P
    Minerva Chir; 1998 Dec; 53(12):979-85. PubMed ID: 10210927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.
    Burch PA; Block M; Schroeder G; Kugler JW; Sargent DJ; Braich TA; Mailliard JA; Michalak JC; Hatfield AK; Wright K; Kuross SA
    Clin Cancer Res; 2000 Sep; 6(9):3486-92. PubMed ID: 10999733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide in control of multiple liver metastases from gastrinoma.
    Saijo F; Naito H; Funayama Y; Fukushima K; Shibata C; Hashimoto A; Kitayama T; Nagao M; Matsuno S; Sasaki I
    J Gastroenterol; 2003; 38(9):905-8. PubMed ID: 14564638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective streptozocin therapy for metastatic pancreatic polypeptide apudoma.
    Friesen SR; Stephens RL; Huard GS
    Arch Surg; 1981 Aug; 116(8):1090-2. PubMed ID: 6455109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors.
    Oberg K
    Expert Rev Anticancer Ther; 2009 May; 9(5):557-66. PubMed ID: 19445573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced endocrine gastroenteropancreatic tumours using radiolabelled somatostatin analogues.
    Van Eijck CH
    Br J Surg; 2005 Nov; 92(11):1333-4. PubMed ID: 16237740
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of somatostatin analogs in the treatment of endocrine gastrointestinal tumors.
    Trautmann ME; Neuhaus C; Lenze H; Benning R; Benning M; Dennler HJ; Bruns C; Joseph K; Arnold R
    Horm Metab Res Suppl; 1993; 27():24-7. PubMed ID: 8392487
    [No Abstract]   [Full Text] [Related]  

  • 16. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
    Weckbecker G; Raulf F; Bodmer D; Bruns C
    Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Somatostatinoma syndrome].
    Varas Lorenzo MJ
    Med Clin (Barc); 1982 Mar; 78(6):246-9. PubMed ID: 6123632
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical response of an atypical glucagonoma treated with a long-acting somatostatin analog].
    Bouin M; Aoust LD
    Gastroenterol Clin Biol; 2002 Oct; 26(10):926-9. PubMed ID: 12434103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
    Robben JH; Visser-Wisselaar HA; Rutteman GR; van Rijk PP; van Dongen AJ; Voorhout G; van den Ingh TS; Hofland LJ; Lamberts SW
    J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric evidence of apoptosis in human pancreatic cancer xenografts treated with Sandostatin (octreotide).
    Zalatnai A; Szegedi Z; Bocsi J
    Anticancer Res; 2000; 20(3A):1663-6. PubMed ID: 10928088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.